Neurofilament light (NfL), medium (NfM) and heavy (NfH) proteins have recently emerged as potential biomarkers for axonal damage in various neurodegenerative diseases, such as FTLD, Alzheimer`s disease (AD) and Parkinson`s disease (PD) [4]. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.